More blood pressure, heart failure medications added to FDA recall More companies have been added to an FDA recall of blood pressure medicin...
More companies have been added to an FDA recall of blood pressure medicine containing a possible carcinogen.
Click or tap here to see the updated list, which expands upon the original valsartan-containing drugs to at least 40 products with varying pill counts.
An impurity called N-nitrosodimethylamine (NDMA) was found in the drugs. NDMA is classified as a probable human carcinogen based on lab tests.
Next Story
Not Available
Just For You
Not Available
Tre nding
Not AvailableEarlier: FDA recalls blood pressure, heart failure medications after finding of cancer- causing impurity
The FDA says the list now includes valsartan-containing products manufactured by Hetero Labs Limited, in India, labeled as Camber Pharmaceuticals Inc.
© 2018 KSDKSource: Google News US Health | Netizen 24 United States
